| RS2134012580 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134012749 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134013121 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type B |
| RS2134013240 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS2134013368 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS2134017039 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134017306 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS2134017443 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS2134017711 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type B |
| RS2134017940 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134017952 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134018090 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134019797 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS2134020777 |
LGI1
|
Health Risk |
Likely pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134020912 |
LGI1
|
Health Risk |
Pathogenic |
— |
| RS2134020917 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2134021058 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type B |
| RS2134021440 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134021516 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134021618 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134022652 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134023240 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type B |
| RS2134023610 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS2134023663 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS2134024060 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS2134024349 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS2134025769 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS2134026453 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2134026513 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134026684 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134026711 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2134026964 |
LGI1
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Epilepsy |
| RS2134027169 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS2134027207 |
LGI1
|
Health Risk |
Likely pathogenic |
— |
| RS2134048726 |
RRAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, Germinoma |
| RS2134049595 |
PDZD7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2134050486 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134050674 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134058885 |
CD3D
|
Health Risk |
Likely pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS2134063372 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134063421 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134064890 |
BAG3
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134064900 |
BAG3
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134064943 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065052 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134065084 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Myocarditis, Primary dilated cardiomyopathy |
| RS2134065136 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065158 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065221 |
BAG3
|
Health Risk |
Pathogenic |
— |
| RS2134065242 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065278 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065350 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134065363 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134068305 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS2134068635 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134068763 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134068813 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134068860 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134068940 |
BAG3
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2134068984 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134069115 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2134069217 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134069248 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2134069295 |
BAG3
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2134069699 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS2134074165 |
PDZD7
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 57 |
| RS2134076706 |
EBF3
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2134081192 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS2134082367 |
CYP17A1
|
Health Risk |
Pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |
| RS2134082641 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134082781 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134082911 |
NDUFV1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS2134083298 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134083338 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134083893 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134083915 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134085151 |
NDUFV1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS2134085596 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134085637 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134085666 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS2134088502 |
PDZD7
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 57 |
| RS2134088808 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS2134089305 |
UBE4A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and gross motor and speech delay, Neurodevelopmental disorder with hypotonia and gross motor and speech delay |
| RS2134090994 |
OTOG
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS2134091591 |
OTOG
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2134092709 |
UBE4A
|
Health Risk |
Pathogenic |
UBE4A-related disorder, UBE4A-related disorder |
| RS2134092983 |
BLNK
|
Health Risk |
Likely pathogenic |
Agammaglobulinemia 4, autosomal recessive |
| RS2134093224 |
PTH
|
Health Risk |
Pathogenic |
Hypoparathyroidism, familial isolated 1 |
| RS2134093283 |
PTH
|
Health Risk |
Likely pathogenic |
— |
| RS2134097007 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2134100484 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS2134100639 |
ERLIN1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2134108087 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS2134108223 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2134108332 |
EBF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, ataxia |
| RS2134121169 |
SHOC2
|
Health Risk |
Likely pathogenic |
Noonan syndrome-like disorder with loose anagen hair 1, Noonan syndrome-like disorder with loose anagen hair 1 |
| RS2134121762 |
SHOC2
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2134129636 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS2134129705 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS2134129845 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |